APOE and dementia: In the development of a potential screening approach, a decision tree was performed considering the neuropsychological tests (dementia, non-dementia), the previously validated diagnosis model (positive, negative), and the genotype ApoE (allele ε4 carrier, non-carrier) (Figure 1).